You just read:

Data Presented at ESMO 2016 Demonstrates that VolitionRx Limited's Novel Blood Test for Colorectal Cancer Potentially Reduces the Need for Colonoscopy Referral by 25%

News provided by

VolitionRx Ltd

Oct 11, 2016, 08:30 ET